The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30‐year experienceAlessandro Broccoli, Pier Luigi Zinzani, Lisa Argnani et al.|American Journal of Hematology|2021Cited by 17
Idelalisib as a Bridge to Allogeneic Transplantation in Relapsed/Refractory Lymphoma With Renal Cancer: A Case ReportGiulia Gabrielli, Pier Luigi Zinzani, Alessandro Broccoli et al.|Clinical Lymphoma Myeloma & Leukemia|2019Cited by 4
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone LymphomaCamilla Mazzoni, Pier Luigi Zinzani, Gabriele Gugliotta et al.|European Journal Of Haematology|2024Cited by 3
Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practiceCinzia Pellegrini, Pier Luigi Zinzani, Beatrice Casadei et al.|Annals of Hematology|2025Cited by 2
Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world studyBeatrice Casadei, Pier Luigi Zinzani, Lisa Argnani et al.|Blood Advances|2025Cited by 2